Advertisement · 728 × 90
#
Hashtag
#CovidCare
Advertisement · 728 × 90
Below is text, however I have underlined
 “ if new evidence emerges or epidemiology changes.” 

ATAGI recommendations
A summary of advice is at Table 1. The Australian Immunisation Handbook COVID-19 chapter has further details, including recommendations for people who have never received a COVID-19 vaccine (a 'primary course').
COVID-19 recommendations are reviewed annually, or earlier if new evidence emerges or epidemiology changes.
ATAGI recommends a COVID-19 vaccine dose every 6 months for:
• Adults aged ≥75 years.
ATAGI recommends a COVID-19 vaccine dose every 12 months for:
• Adults aged 65-74 years
• Adults aged 18—64 years with severe immunocompromise.
These groups are also eligible for a dose every 6 months, based on a benefit-risk assessment. A dose every six months is most likely to benefit people with medical risk conditions and/or those living in residential aged care homes.
The following groups are eligible to receive a COVID-19 vaccine every 12 months, based on a benefit-risk assessment:
• All other adults aged 18-64 years
• Children and adolescents aged 5—<18 years with severe immunocompromise.
Vaccination reduces the risk of severe disease and death from COVID-19.

Below is text, however I have underlined “ if new evidence emerges or epidemiology changes.” ATAGI recommendations A summary of advice is at Table 1. The Australian Immunisation Handbook COVID-19 chapter has further details, including recommendations for people who have never received a COVID-19 vaccine (a 'primary course'). COVID-19 recommendations are reviewed annually, or earlier if new evidence emerges or epidemiology changes. ATAGI recommends a COVID-19 vaccine dose every 6 months for: • Adults aged ≥75 years. ATAGI recommends a COVID-19 vaccine dose every 12 months for: • Adults aged 65-74 years • Adults aged 18—64 years with severe immunocompromise. These groups are also eligible for a dose every 6 months, based on a benefit-risk assessment. A dose every six months is most likely to benefit people with medical risk conditions and/or those living in residential aged care homes. The following groups are eligible to receive a COVID-19 vaccine every 12 months, based on a benefit-risk assessment: • All other adults aged 18-64 years • Children and adolescents aged 5—<18 years with severe immunocompromise. Vaccination reduces the risk of severe disease and death from COVID-19.

Below is text, I’ve underlined 
“5-17 years
Not recommended
<5 years
Not recommended”


Table 1: Timing of further COVID-19 vaccine doses by age group and risk status

≥ 75 years
Recommended every 6 months
Recommended every 6 months
65-74 years
Recommended every 12 months and are eligible for a dose every 6 months
Recommended every 12 months and are eligible for a dose every 6 months
18-64 years
Recommended every 12 months and are eligible for a dose every 6 months
Eligible for a dose every 12 months
5-17 years
Eligible for a dose every 12 months
Not recommended
<5 years
Not recommended
Not recommended

#See the Australian Immunisation Handbook for definitions and examples of severe immunocompromise

"Recommended": benefits of vaccination outweigh the risks for the defined population.
"Eligible": eligible for a free COVID-19 vaccine, and individuals encouraged to discuss their individual circumstances with their healthcare provider.

Below is text, I’ve underlined “5-17 years Not recommended <5 years Not recommended” Table 1: Timing of further COVID-19 vaccine doses by age group and risk status ≥ 75 years Recommended every 6 months Recommended every 6 months 65-74 years Recommended every 12 months and are eligible for a dose every 6 months Recommended every 12 months and are eligible for a dose every 6 months 18-64 years Recommended every 12 months and are eligible for a dose every 6 months Eligible for a dose every 12 months 5-17 years Eligible for a dose every 12 months Not recommended <5 years Not recommended Not recommended #See the Australian Immunisation Handbook for definitions and examples of severe immunocompromise "Recommended": benefits of vaccination outweigh the risks for the defined population. "Eligible": eligible for a free COVID-19 vaccine, and individuals encouraged to discuss their individual circumstances with their healthcare provider.

Thanks Denis
Here are *my* s’shots

•I have to seriously qn their commitment to “if new evidence emerges”
😡
and
•wtaFUCK are we doing to our kids
🤬

🙋‍♀️works in a school

#DutyOfCare

💔

#CovidCare

3 0 0 0

It’s not #CovidAnxiety, it’s #CovidEducation, #CovidMitigation, #CovidCommonsense and #CovidCare.

0 0 0 0

Simple measures...

I still take these supplements, I still mask at school when my CO2 monitor suggests, I'm still Novid and I still haven't infected anyone else with this dangerous disease... #CovidCare

0 0 0 0
Preview
Covid Presentation for MFTs A presentation created by two MFT trainees discussing Long COVID and implications for mental health and clinical practice. Resources are included at the end.

A great Covid resource, not just for therapists (in my non-therapist opinion). To bookmark & share 👇

What therapists need to know about Covid-19 in 2024
covid-for-therapists.my.canva.site

#Covid #People #CovidCare #LongCovid

6 2 2 1